The 3Ks (kava, kratom and khat) are herbals that can potentially induce liver injuries. On the one hand, growing controversial data have been reported about the hepatotoxicity of kratom, while, on the other hand, even though kava and khat hepatotoxicity has been investigated, the hepatotoxic effects are still not clear. Chronic recreational use of kratom has been associated with rare instances of acute liver injury. Several studies and case reports have suggested that khat is hepatotoxic, leading to deranged liver enzymes and also histopathological evidence of acute hepatocellular degeneration. Numerous reports of severe hepatotoxicity potentially induced by kava have also been highlighted, both in the USA and Europe. The aim of this review is to focus on the different patterns and the mechanisms of hepatotoxicity induced by “the 3Ks”, while trying to clarify the numerous aspects that still need to be addressed.
D. vacuolar locations, lysosomal and vacuolar lumen instructions, vacuolar and lysosomal membranes. We conclude that the impact on the phenotype highly depends on the pathogenicity of the variants. In our sample, a high frequency of benign variants was found; however, pathogenic variants were detected, which should be the object of study in precision medicine associated with GD.
Introducción: La Enfermedad de Gaucher (EG) es un trastorno genético autosómico recesivo, causado por la deficiencia de la enzima B-Glucocerebrosidasa acida (GBA). En Colombia se ha estimado una prevalencia de 1:266.441 habitantes. Sin embargo, el país no cuenta con datos exactos sobre la incidencia, prevalencia y carga poblacional de esta enfermedad. Objetivo: Con el objetivo de caracterizar molecularmente las variantes encontradas en el gen GBA presentes en pacientes del Suroccidente Colombiano con enfermedad de Gaucher. Materiales y métodos: Se incluyeron 19 pacientes en el estudio, 57,8% de género masculino, con intérvalo de edad entre 4 y 71 años, diagnosticados clínica y enzimáticamente con EG. Se realizó un análisis molecular del gen GBA y posteriormente se buscaron las variantes en diferentes bases de datos poblacionales y clínicas; además se realizó análisis bioinformático para evaluar el posible impacto de las variantes de interés en la estructura y funcionalidad de la proteína. Resultados: Se encontraron 14/19 pacientes homocigotos; 4/19 heterocigotos compuestos y 1/19 heterocigotos). Se reportó la presencia de 7 variantes que codifican para 8 genotipos diferentes. El genotipo más frecuente es p.Asn409Ser/p.Asn409Ser (36%). De las 7 variantes encontradas, se reportó que específicamente p. Asn409Ser (10/23 alelos) y p.Leu483Pro (3/23 alelos) y p.Lys237Glu (3/23 alelos), están presentes en el 69,5% de los alelos. Todas las variantes presentaron una significancia clínica patogénica. Conclusiones: Este trabajo contribuye al establecimiento de las bases moleculares de la EG en los pacientes del Suroccidente Colombiano, permitiendo realizar una correlación genotipo-endotipo-fenotipo. Así mismo, se determina que los algoritmos de diagnóstico que incluyen análisis molecular y herramientas predictivas bioinformáticas permiten mejorar el diagnóstico, el tratamiento y el pronóstico de los pacientes afectados por EG, generando un impacto positivo en el seguimiento de los afectados, de la mano de una correcta consejería genética y estudios de portadores.
Mucopolysaccharidosis is characterized by excessive accumulation of glycosaminoglycan sulfate in organs and tissues. Otorhinolaryngological and upper respiratory tract pathologies are among the earliest clinical manifestations. We realized a retrospective study of clinical and otorhinolaryngologic findings of 35 patients diagnosed with MPS type II, IV-A and VI of the Colombian southwest. As a result, we found that 64% of the patients evaluated had hearing loss, 11.3% had hypertrophy of the tonsils,17.10% short neck and macroglossia. Additionally, 47.8% of the patients presented otitis media. 20% received treatment with hearing aids. no patient reported otosclerosis or tinittus. In patients with different types of MPS, there is a high frequency and progressive tendency to suffer audiological losses and recurrent infections, so it is important an opportune diagnosis, permanent monitoring and adequate therapy to avoid the repercussion of the pathology in the quality of life of patients.
Introduction: Gaucher's disease (GD) is an autosomal-recessive lysosomal storage disorder that results from hereditary deficiency of the acid glucocerebrosidase enzyme, encoded by the GBA gene necessary for the degradation of glucosylceramide. Objective: molecularly characterize the variants found in the GBA gene present in patients from the Southwest of Colombia with GD. Material and methods: 19 patients were included in the study, clinically and enzymatically diagnosed with GD. A molecular analysis of the GBA gene was performed and the variants were subsequently searched in different population and clinical databases. A bioinformatic analysis was performed. Results:The variants in the GBA gene reported were classified into: 14/19 homozygous patients, 4/19 compound heterozygote and 1/19 heterozygous. The presence of 7 variants coding for 8 different genotypes was reported. Also the known mutations like Asn409Ser, p.Leu483Pro, p.Lys237Glu, p.Glu427Lys, and p.Arg535His were identified in these patients. The most frequent genotype was p. Asn409Ser / Asn409Ser (36%). All the variants presented a pathogenic clinical significance. Conclusion:The given study will make it possible to understand the susceptibility to GD in the population. This can help maintain the health quotient of the population through premarital counseling and therefore minimize the burden of disease among the population.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.